NOT-ES-24-006: Notice of Clarification to NIEHS' Participation in PA-23-230 "PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)"

Notice of Clarification to NIEHS' Participation in PA-23-230 "PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)"

Notice Number:

NOT-ES-24-006

Key Dates

Release Date:

January 18, 2024

Related Announcements

July 12, 2023 - PHS 2023 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed). See NOFO PA-23-230.

Issued by

National Institute of Environmental Health Sciences (NIEHS)

Purpose

The purpose of this Notice is to inform potential applicants that the National Institute of Environmental Health Sciences (NIEHS) Superfund Hazardous Substances Basic Research and Education (known as the Superfund Research Program, or SRP) and the Worker Training Program (WTP) are participating, effective immediately, in PA-23-230, “PHS 2023-2 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)”.

The following text has been added to PA-23-230 to reflect SRP’s and WTP's participation in this Notice of Funding Opportunity.

Assistance Listing Number(s)

93.143

93.142

All other aspects of PA-23-230 remain unchanged.

Inquiries

Please direct all inquiries to:

Heather Henry, PhD
Superfund Research Program
National Institute of Environmental Health Sciences
Telephone: 984-287-3268
Email: [email protected]